当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:305.35亿  总市值:305.35亿
流通股本:12.64亿   总股本:12.64亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,690,261,144.281,093,038,877.15428,230,392.312,438,221,560.56
  收到的税费返还---1,489,586.81
  收到其他与经营活动有关的现金118,423,147.2193,595,267.9148,814,241.98139,241,305.72
  经营活动现金流入小计1,808,684,291.491,186,634,145.06477,044,634.292,578,952,453.09
  购买商品、接受劳务支付的现金441,586,557.83293,359,008.61144,578,081.77643,215,533.89
  支付给职工以及为职工支付的现金817,511,589.15585,146,072.15352,833,940.71,034,628,104.58
  支付的各项税费143,327,127.06103,313,371.3659,140,142.78164,693,486.34
  支付其他与经营活动有关的现金493,479,772.2286,140,326.62152,536,705.67646,661,285.18
  经营活动现金流出小计1,895,905,046.241,267,958,778.74709,088,870.922,489,198,409.99
  经营活动产生的现金流量净额-87,220,754.75-81,324,633.68-232,044,236.6389,754,043.1
二、投资活动产生的现金流量:
  收回投资收到的现金5,780,523,626.685,068,135,631.643,526,131,777.474,647,311,628.27
  取得投资收益收到的现金135,798,781.32106,743,737.3997,123,533.24114,450,861.91
  处置固定资产、无形资产和其他长期资产收回的现金净额7,4213,5211,623210,726,017.05
  收到的其他与投资活动有关的现金---5,775,292.24
  投资活动现金流入小计5,916,329,8295,174,882,890.033,623,256,933.714,978,263,799.47
  购建固定资产、无形资产和其他长期资产支付的现金351,584,361.56214,356,455.96100,204,503.7805,164,493.44
  投资支付的现金---4,929,122,930.22
  支付其他与投资活动有关的现金5,169,504,427.94,699,504,427.93,207,504,427.92,985,107.8
  投资活动现金流出小计5,521,088,789.464,913,860,883.863,307,708,931.65,737,272,531.46
  投资活动产生的现金流量净额395,241,039.54261,022,006.17315,548,002.11-759,008,731.99
三、筹资活动产生的现金流量:
  取得借款收到的现金237,421,867.44136,036,105.7967,370,265.08343,558,490.81
  收到其他与筹资活动有关的现金548,627.15--299.26-
  筹资活动现金流入小计237,970,494.59136,036,105.7967,369,965.82343,558,490.81
  偿还债务支付的现金257,858,588.04183,196,291.1258,454,271.17319,007,771.34
  分配股利、利润或偿付利息支付的现金1,757,329.711,192,170.82222,620.032,277,526.66
  支付其他与筹资活动有关的现金2,297,828.71,969,335.71,434,098.221,801,532.2
  筹资活动现金流出小计261,913,746.45186,357,797.6460,110,989.4343,086,830.2
  筹资活动产生的现金流量净额-23,943,251.86-50,321,691.857,258,976.42471,660.61
四、汇率变动对现金及现金等价物的影响-35,461,160.73-25,684,302.87-12,590,723.87-13,270,093.55
五、现金及现金等价物净增加额248,615,872.2103,691,377.7778,172,018.03-682,053,121.83
  加:期初现金及现金等价物余额1,344,952,704.671,344,952,704.671,344,952,704.672,027,005,826.5
  期末现金及现金等价物余额1,593,568,576.871,448,644,082.441,423,124,722.71,344,952,704.67
补充资料:
  净利润--132,375,087.05--413,963,529.44
  资产减值准备-27,956,086.18-207,361,022.12
  固定资产和投资性房地产折旧-151,364,655.65-262,816,779.48
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-151,364,655.65-262,816,779.48
  无形资产摊销-35,115,634.51-53,278,499.24
  长期待摊费用摊销-10,279,255.26-21,725,256.4
  处置固定资产、无形资产和其他长期资产的损失-1,418,439.81--60,231,327.31
  固定资产报废损失-496,582.69-2,193,208.09
  公允价值变动损失--10,324,525.44--48,297,071.98
  财务费用-23,237,872.04-14,660,009.6
  投资损失--32,602,360.45--66,215,195.97
  递延所得税--23,394,799--94,845,344.69
  其中:递延所得税资产减少--23,394,799--94,845,344.69
  存货的减少--98,893,210.5--40,540,197.18
  经营性应收项目的减少-6,818,431.99-398,160,460.04
  经营性应付项目的增加--88,104,806.38--183,403,743.15
  其他--3,555,225.52--14,145,472.91
  不涉及现金收支的投资和筹资活动金额其他项目-34,825,432.52-8,341,962.59
  现金的期末余额-1,448,644,082.44-1,344,952,704.67
  减:现金的期初余额-1,344,952,704.67-2,027,005,826.5
  现金及现金等价物的净增加额-103,691,377.77--682,053,121.83
公告日期2026-10-272026-08-202026-04-282026-04-21
审计意见(境内)标准无保留意见
TOP↑